SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-21-020807
Filing Date
2021-08-20
Accepted
2021-08-20 16:06:50
Documents
1
Period of Report
2021-08-20

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3762
  Complete submission text file 0001493152-21-020807.txt   5151
Mailing Address C/O ETON PHARMACEUTICALS, INC. 21925 W FIELD PKWY #235 DEER PARK IL 60010
Business Address
BRYNJELSEN SEAN (Reporting) CIK: 0001669976 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38738 | Film No.: 211193885

Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Issuer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations